Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

January 16, 2026 • President Trump threatens to invoke the Insurrection Act in Minnesota to stop protests happening in Minneapolis. And, the president unveils what he calls a new healthcare plan.